Hydrocortisone-butyrate-figure-1-hydrocortisone_butyrate_structure.jpg (Hydrocortisone Butyrate Ointment 1)
Hydrocortisone Butyrate Ointment
Product Images NDC 68682-271
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrocortisone Butyrate (NDC 68682-271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 01
This is the product label for a medication called Hydrocortisone Butyrate Ointment 0.1%. The ointment is manufactured by Ferncale Laboratories, Inc. and distributed by Oceanside Pharmaceuticals, a division of Bausch Health US, LLC. The product is for topical use only and is not to be used for ophthalmic purposes. Each gram of the ointment contains a certain amount of hydrocortisone butyrate in a mineral oil and polyethylene base. The recommended dosage is to apply a thin layer to the affected areas 2 to 3 times daily, or as directed by a physician. The product should be kept out of reach of children and stored at a controlled temperature between 2° to 30°C (36° to 86°F).*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
